What is a cancer patient support service business in India?

A non-clinical support service helping cancer patients at public hospitals with treatment navigation, medicine procurement, transport coordination, and counselling. It is NOT medical treatment or diagnosis—you act as a bridge between patients, hospitals, and pharmacies. The ₹120 crore addressable market in India is driven by 5,000+ new cancer patients yearly at major public facilities like Sion Hospital, Mumbai, who need affordable, accessible support.

How much does it cost to start a cancer patient support service in India?

₹5,000–10,000 for business registration (proprietorship/partnership) + ₹500–2,000 for GST registration (if revenue exceeds ₹20 lakh/year) + ₹50,000–1,00,000 for initial operations (office, staff, transport coordination setup). Total initial capital: ₹55,000–1,12,000. No medical license required.

Is a cancer patient support service profitable in India?

Yes. Market research shows ₹2,400 average annual spend per patient × 5,000+ patients = ₹12 crore+ annual revenue potential per hospital. After 5% service tax (GST) and 30–40% operating costs, net margins of 30–50% are achievable. Profitability scales with patient volume and geographic expansion to other public hospitals.

What regulations apply to cancer patient support services in India?

Business registration under Indian Partnership Act, 1932 or as sole proprietorship; GST registration under GST Act, 2017 (5% service tax on patient support services); compliance with Bharatiya Nyaya Sanhita, 2023 for consumer protection; and adherence to pharmacy regulations (Drugs and Cosmetics Act, 1940, Section 21) when sourcing medicines. No medical license required as long as you do NOT diagnose, prescribe, or administer treatment.

Cancer Patient Support Services India 2026 | ₹120Cr Market

AI SummaryCancer patient support services address a ₹120 crore annual market in India, driven by public hospital expansion and rising cancer incidence among low-income populations. With Sion Hospital, Mumbai's new 200-bed cancer unit treating 5,000+ patients yearly, the timing in 2026 is critical: government healthcare push, GST clarity on health services, and high unmet demand create a scalable opportunity. Social entrepreneurs, healthcare professionals, and NGOs should pursue this to deliver affordable support (treatment navigation, medicine sourcing, transport coordination) to underserved cancer patients while building a sustainable, profitable business.